LIVE Day Two – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 9, 2019
Reporter: Aviva Lev-Ari, PhD, RN
www.worldmedicalinnovation.org
The Forum will focus on patient interactions across care settings, and the role technology and data can play in advancing knowledge discovery and care delivery. The agenda can be found here.
https://worldmedicalinnovation.org/agenda/
Leaders in Pharmaceutical Business Intelligence (LPBI) Group
represented by Founder & Director, Aviva Lev-Ari, PhD, RN will cover this event in REAL TIME using Social Media
3.1.3 LIVE Day Two – World Medical Innovation Forum ARTIFICIAL INTELLIGENCE, Boston, MA USA, Monday, April 9, 2019, Volume 2 (Volume Two: Latest in Genomics Methodologies for Therapeutics: Gene Editing, NGS and BioInformatics, Simulations and the Genome Ontology), Part 2: CRISPR for Gene Editing and DNA Repair
Tuesday, April 9, 2019
Bayer Ballroom
Bayer Ballroom
Implementing AI in Cancer Care
With AI-enabled care strategies and digital technologies, clinicians and patients are embracing new approaches to improve the lives of cancer patients through enhanced diagnosis and treatment. These include AI-guided tools for more precise methods of predicting risk, more effective screening strategies, patient data driven insights and more personalized treatments. Panelists will engage on how these and other innovations are enabling a new era of cancer care.
Bayer Ballroom
Imagining Medicine in the Year 2054
In 1984 Isaac Asimov was asked to predict what life in 2019 would be like. Using the same aperture, we as what will constitute health care 35 years from now? Current trends suggest that there will be significant gains in immunotherapy, gene therapy, and breakthrough treatments for neurologic, cardiovascular and oncologic diseases. Panelists will draw on their visionary perspective and will reflect on what to expect and why.
Bayer Ballroom
Bayer Ballroom
Bayer Ballroom
CEO Roundtable
Chief executives share perspectives on the impact of AI on their respective companies and industry segments. Panelists will discuss their views of AI, how AI figures into their organizations’ current product and investment strategies, and how they are measuring return on existing AI investments. The panel will also address opportunities and challenges surrounding AI, ranging from workforce needs to managing bias in AI development.
Bayer Ballroom
Discovery Cafe Sessions
Provider Back Office of the Future
The application of AI-based technologies to the business side of health care — including functions such as billing, payment, and insurance claims management — could lead to significant improvements in health care operations and efficiency, with billions of dollars in savings each year. Panelists will discuss emerging tools and technologies as well as the opportunities and pitfalls of using AI to innovate and automate back office functions.
Moderator: Peter Markell, EVP, Administration and Finance, CFO and Treasurer, PHS
Inge Harrison, CNO/VP of Strategic Advisory Services, Verge Health
Kent Ivanoff, CEO, VisitPay
Mary Beth Remorenko, VP, Revenue Cycle Operations, PHS
Brian Robertson, CEO, VisiQuate
Chief Digital Strategy Officer Roundtable
With the advent of AI-enabled technologies, this session brings together leading chief digital health officers. The discussion will address tradeoffs in sequencing technology across academic medical centers; what technologies are being prioritized; and consumer expectations.
Moderator: Alistair Erskine, MD, Chief Digital Health Officer, PHS
Michael Anderes, Chief Innovation and Digital Health Officer, Froedtert Health; President, Inception Health
Adam Landman, MD, VP and CIO, BH; Associate Professor of Emergency Medicine, HMS
Aimee Quirk, CEO, innovationOchsner
Richard Zane, MD, Chief Innovation Officer, UCHealth; Professor and Chair,Department of Emergency Medicine, University of Colorado School of Medicine
Innovation Fellows: A New Model of Collaboration
The Innovation Fellows Program provides experiential career development opportunities for future leaders in health care. It facilitates personnel exchanges between Harvard Medical School staff from Partners’ hospitals and participating biopharmaceutical, device, venture capital, digital health, payor and consulting firms. Fellows and Hosts learn from each other as they collaborate on projects ranging from clinical development to digital health and artificial intelligence. Learn how this new model of collaboration can deliver value and lead to broader relationships between industry and academia.
Moderator: Seema Basu, PhD, Market Sector Leader, Innovation, PHS
Nathalie Agar, PhD, Research Scientist, Neurosurgery, BH; Associate Professor, Neurosurgery, Radiology, HMS
Paul Anderson, MD, PhD, Chief Academic Officer, BH; SVP, Research, BH; K. Frank Austen Professor of Medicine, HMS
Laurie Braun, MD, Partners Innovation Fellow, MGH and Boston Pharmaceuticals; Instructor in Pediatrics, HMS
David Chiang, MD, PhD, Research Fellow, BH; Innovation Fellow, Boston Scientific
David Feygin, PhD, Chief Digital Health Officer, Boston Scientific
Peter Ho, MD, PhD, CMO, Boston Pharmaceuticals
Harry Orf, PhD, SVP, Research, MGH; Principal Associate, HMS
Last Mile: Fully Implementing AI in Healthcare
This session will focus on how radiology and pathology specialties are currently applying AI in the clinic. Where will it be built out first? What are the barriers and how will these challenges be overcome?
Moderator: Keith Dreyer, DO, PhD, Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
Katherine Andriole, PhD, Director of Research Strategy and Operations, MGH & BWH CCDS; Associate Professor, Radiology, HMS
Samuel Aronson, Executive Director, IT, Personalized Medicine, PHS
Peter Durlach, SVP, Healthcare Strategy & New Business Development, Nuance
Seth Hain, VP of R&D, Epic
Jonathan Teich, MD, PhD, Chief Medical Information Officer, InterSystems; Emergency Medicine, BH
Reimagining Disease Management
The management of disease has become vastly more challenging, both for patients and providers. AI-based technologies promise to improve and streamline patient care through a variety of approaches. This session will feature a discussion of these new tools and how they can enhance patient engagement and optimize care management.
Moderator: Sree Chaguturu, MD, Chief Population Health Officer, PHS; Assistant Professor, Medicine, HMS
Murray Brozinsky, Chief Strategy Officer, Conversa
Jean Drouin, MD, CEO, Clarify Health Solutions
Julian Harris, MD, President, CareAllies
Erika Pabo, MD, Chief Health Officer, Humana Edge; Associate Faculty, Ariadne Labs; Associate Physician, BH; Instructor, HMS
Standards and Regulation: The Emerging AI Framework
As the health care industry faces an explosion of AI-based tools, the FDA’s approach to these technologies is evolving. This session will focus on the agency’s approach to AI-based products, how to calculate the risk profile of these new technologies, and the challenges of securing adequate data rights.
Moderator: Brent Henry, Member, Mintz Levin
Bethany Hills, Member/ Chair, FDA Practice, Mintz Levin
Michelle McMurry-Heath, MD, PhD, VP, Global Regulatory Affairs and International Clinical Evidence, Johnson & Johnson Medical Devices
Bakul Patel, Associate Director, Digital Health, FDA
Michael Spadafore, Managing Director, Sandbox Industries
From Startup to Impact (Provider Solutions)
This session will introduce you to five leading startup companies who will each share their respective impact in delivery provider solutions in ten-minute pitches.
Moderator: Meredith Fisher, PhD, Partner, Partners Innovation Fund, PHS
Moderator: James Stanford, Managing Director, Fitzroy Health
William Grambley, COO, AllazoHealth
Gal Salomon, CEO, CLEW
Siddarth Satish, CEO, Gauss Surgical
Pelu Tran, CEO, Ferrum Health
Ed Zecchini, CIO, Remedy Partners
Bayer Ballroom
China: AI Enabled Healthcare Leadership
China’s health care system faces major challenges — and its population is aging more rapidly than nearly every other country. To help address these problems, the Chinese health technology sector is strongly embracing AI. What are the most exciting applications? What lessons does China’s early forays into AI-enabled patient care hold for other health care systems?
Bayer Ballroom
Bayer Ballroom
Getting to the AI Investment Decision
The billions invested worldwide in AI-based health care technologies underscore the enthusiasm of global investors. But where are the greatest opportunities and what is the timeline to meaningful impact? In this panel, venture, private equity investors, and buy side analysts will discuss investment priorities, timelines, and key areas of interest
Bayer Ballroom
Bayer Ballroom
Consumer Healthcare and New Models of Care Delivery
Al is powering a revolution in consumer health care, giving patients a deeper role in monitoring their own health and spawning new models of care delivery. Many health care organizations are increasingly focused on creating a digital “front door” for patients – a single gateway to mobile apps and other online services. Panelists will also discuss the role of remote monitoring and virtual care programs as well as the role of Al in care redesign and workflow.
Bayer Ballroom
BioBank Award Announcement
- Third place MGH – Computational Pathology
- First Prize – $12,000 UPittsburg – Dept Biomedical Informatics – principal components
- First Prize – IBM Center for Computational Health – supervised algorithm
Leave a Reply